Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to sacituzumab govitecan in triple-negative breast cancer. Coates, J. T, Sun, S., Leshchiner, I., Thimmiah, N., Martin, E. E, McLoughlin, D., Danysh, B. P, Slowik, K., Jacobs, R. A, Rhrissorrakrai, K., & others Cancer discovery, 11(10):2436–2445, American Association for Cancer Research, 2021.
bibtex   
@article{coates2021parallel,
  title={Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to sacituzumab govitecan in triple-negative breast cancer},
  author={Coates, James T and Sun, Sheng and Leshchiner, Ignaty and Thimmiah, Nayana and Martin, Elizabeth E and McLoughlin, Daniel and Danysh, Brian P and Slowik, Kara and Jacobs, Raquel A and Rhrissorrakrai, Kahn and others},
  journal={Cancer discovery},
  volume={11},
  number={10},
  pages={2436--2445},
  year={2021},
  publisher={American Association for Cancer Research}
}

Downloads: 0